PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-42.27%
Negative net income growth while 1097.HK stands at 76.47%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.22%
Some D&A expansion while 1097.HK is negative at -43.91%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-814.38%
Negative yoy deferred tax while 1097.HK stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-703.50%
Negative yoy SBC while 1097.HK is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-154.56%
Both reduce yoy usage, with 1097.HK at -6.88%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth well above 1097.HK's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
100.00%
Inventory growth well above 1097.HK's 100.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-100.00%
Negative yoy AP while 1097.HK is 185.84%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-921.71%
Both reduce yoy usage, with 1097.HK at -123.46%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-13.18%
Both negative yoy, with 1097.HK at -109.01%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-63.88%
Both yoy CFO lines are negative, with 1097.HK at -165.46%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
22.53%
Lower CapEx growth vs. 1097.HK's 65.36%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-95.98%
Both yoy lines negative, with 1097.HK at -6204.31%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-142.48%
Negative yoy purchasing while 1097.HK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-51.78%
We reduce yoy sales while 1097.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
14.39%
We have some outflow growth while 1097.HK is negative at -155.09%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-60.55%
We reduce yoy invests while 1097.HK stands at 34.59%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-38.36%
Negative yoy issuance while 1097.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.